Form 4: Select Medical Director James Ely III Receives Restricted Stock Grant

Select Medical Holdings Corp. Director James S. Ely III was granted 14,035 shares of restricted common stock, enhancing his beneficial ownership to 161,674 shares.

Summary

• James S. Ely III, a Director of Select Medical Holdings Corp. (SEM), was granted 14,035 shares of common stock.
• The transaction date for this grant was July 29, 2025.
• The shares were granted at a price of $0, indicating a restricted stock award rather than a purchase.
• Following this transaction, James S. Ely III beneficially owns 161,674 shares of Select Medical Holdings Corp. common stock directly.
• The restricted stock grant is subject to certain exceptions and will vest in full on July 29, 2026, which is the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is positive as it represents a standard equity grant to a director, aligning their interests with shareholders and indicating continued commitment to the company. It is not a major financial event but a routine positive for corporate governance.

Positives

• The grant of restricted stock aligns the interests of Director James S. Ely III with those of the shareholders, as the value of his compensation is tied to the company's stock performance.
• The vesting schedule encourages long-term commitment and retention of key board members.

Future Outlook

The restricted stock grant is scheduled to vest in full on July 29, 2026, indicating a future milestone for the director's equity compensation.

Industry Context

This Form 4 filing reports a routine insider transaction related to director compensation, which is a common practice across various industries, including healthcare services, to align management and board interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• The restricted stock grant will vest in full on July 29, 2026.

Key Dates

Keywords

Select Medical Holdings Corp, SEM, Restricted Stock, Insider Transaction, Form 4, Director Compensation, Equity Grant, Healthcare Services